Cancer Vaccine

Biotech receives patent allowance for nonlethal hemocyanin extraction method

Published in Cancer Weekly, November 23rd, 2004

Stellar Biotechnologies, Inc. has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application entitled "Non-lethal Method for Extracting Crude Hemocyanin from Gastropod Molluscs."

The patent, when issued, will protect a key component of Stellar's technology related to the production of keyhole limpet hemocyanin (KLH) for vaccines, and it will significantly strengthen the company's intellectual property position. Stellar is a developer of hemocyanin-based immunogenic carrier proteins for anti-cancer vaccines and other therapeutic and preventative vaccine applications.

The company's lead product, KLH, is a highly...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-11-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry